Toggle navigation
Home
Search
Services
Blog
Contact
About
Phase 1 and Phase 2 Clinical Trials of Agents for Cancer Prevention
Search grants from
Share this grant:
:
:
Abstract
Funding
Related projects
Comments
Recent in Grantomics:
Fred Hutchinson Cancer Research Center
vs. funders. Who wins?
Read more...
How should you pick the next fundable research topic?
Read more...
Recently viewed grants:
The Regulatory Code Governing Placenta-Specific Expression of the Chromosome 19 MiRNA Cluster
Mitochondrial Transcription and Pediatric Disease
Melanoma Associated T and DC Dysfunction and Death
HLA Class II Genes;Regulation of Expression
Establishment of Departments of Family Medicine
Recently added grants:
Developing second generation SCID pig models: filling the gaps to improve translation of therapeutics in regenerative medicine
Using a Humanized Microbiome Mouse Model to Assess Therapeutic Response in Glioblastoma
Integrated Microphysiological System of Cerebral Organoid and Blood Vessel for Disease Modeling and Neuropsychiatric Drug screening
Point of Care Diagnostic test for Molecular Subtyping of Breast Cancer (PoCBreCa Study)
Reprogramming the chimeric antigen receptor T cell epigenome to augment anti-tumor activity
Abstract
Funding Agency
Agency
National Institute of Health (NIH)
Institute
National Cancer Institute (NCI)
Type
Research and Development Contracts (N01)
Project #
N01CN35000-8-0-1
Application #
7579487
Study Section
Project Start
2003-09-30
Project End
2008-09-29
Budget Start
Budget End
Support Year
Fiscal Year
2007
Total Cost
Indirect Cost
Related projects
NIH 2008
N01 CA
Phase 1 and Phase 2 Clinical Trials of Agents for Cancer Prevention
/ Mayo Clinic, Rochester
$2,258,000
NIH 2007
N01 CA
Phase 1 and Phase 2 Clinical Trials of Cancer Chemopreventive Agents
Limburg, Paul J. /
$2,257,713
NIH 2007
N01 CA
Phase 1 and Phase 2 Clinical Trials of Agents for Cancer Prevention
/
Comments
Be the first to comment on this grant